GlaxoSmithKline (GSK), a global pharmaceutical industry leader, wanted to review the structure of their batch production record and associated workflows as part of a continuous improvement process. GSK chose Aspen Production Execution Manager to ensure procedural control, thereby speeding up batch release time. The solution has significantly reduced the burden on plant operators by simplifying the batch record and automating the process. Since the pilot project was a huge success, GSK plans to further roll out the technology across all target operations in a phased approach. They see Aspen Production Execution Manager as a key component towards meeting their end goal of zero defects.